Immunosuppressive therapy of myocarditis and inflammatory cardiomyopathy in the light of new data

Eur Heart J. 2022 Dec 1;43(45):4758-4759. doi: 10.1093/eurheartj/ehac500.

Authors

Krzysztof Ozieranski¹, Agata Tyminska¹, Alida L P Caforio²

Affiliations

¹ First Department of Cardiology, Medical University of Warsaw, 1a Banacha St., Warsaw 02-097, Poland.
² Department of Cardiology, Department of Cardiac Thoracic Vascular Sciences and Public Health, University of Padova, Via Giustiniani 2, 35128 Padua, Italy.

PMID: 36263783
DOI: 10.1093/eurheartj/ehac500

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Cardiomyopathy, Dilated* / therapy
Humans
Immunosuppression Therapy
Immunosuppressive Agents / therapeutic use
Myocarditis* / drug therapy

Substances

Immunosuppressive Agents